Demand For Rapid HIV Testing On The Rise
This article was originally published in The Gray Sheet
Executive Summary
The demand for rapid HIV testing is on the rise with a steady stream of new cases and as populations with the disease becomes more difficult to diagnose and treat, speakers at an American Association for Clinical Chemistry audioconference said June 19
You may also be interested in...
CDC Guidelines Will Expand HIV Testing If Physicians, States Follow Lead
Revised recommendations for HIV screening from the Centers for Disease Control & Prevention (CDC) could translate to a greater demand for rapid HIV tests
FDA Panel Mulls Clinical Studies, Labeling For Over-The-Counter HIV Tests
Over-the-counter (OTC) HIV test kits would answer an unmet need, but clinical trials and product labeling must be carefully crafted to ensure that benefits outweigh the risks, according to FDA's Blood Products Advisory Committee
IGI Bets On Trispecific Antibody To Make Inroads Into Big Pharma Myeloma Turf
Ichnos Glenmark Innovation’s president and CEO talks to Scrip about the promising activity profile of the alliance’s early stage trispecific antibody versus Janssen’s teclistamab and also maintains that the setback for Gilead’s magrolimab hasn’t eclipsed prospects for its bispecific antibody.